Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,130.00    80.00 (1.13%)
Bid:
7,110.00
Ask:
7,120.00
Spread: 10.00 (0.141%)
Market Cap: £9.56b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Interim Management Statement

1 Aug 2011 07:00

RNS Number : 4184L
Diploma PLC
01 August 2011
 



 

DIPLOMA PLC

12 CHARTERHOUSE SQUARE, LONDON EC1M 6AX

TELEPHONE: +44 (0)20 7549 5700

FACSIMILE: +44 (0)20 7549 5715

 

FOR IMMEDIATE RELEASE

 

1 August 2011

 

 

 

 

DIPLOMA PLC

 

SECOND INTERIM MANAGEMENT STATEMENT

IN RESPECT OF YEAR ENDING 30 SEPTEMBER 2011

 

 

Diploma PLC, the international group of businesses supplying specialised technical products and services, is today issuing its second Interim Management Statement which relates to the period from 1 April 2011 to date.

 

Group Trading Summary

The strong underlying revenue and profit performance experienced in the first half of the year has continued into the second half of the year. Revenues for the nine months to 30 June 2011 were 28% ahead of the comparable period in 2010. After adjusting for currency effects and acquisitions, underlying revenues for the nine month period increased by ca. 18%; the underlying increase in third quarter revenues was 14% against a stronger prior year comparative.

 

Operating margins have remained at similar levels to those experienced in the first half of the year, despite further incremental investment being made in headcount and operating resources to meet the significant increase in activity.

 

Sector Trading

Trading conditions remain consistent with those reported in the Interim Report in May 2011. In Life Sciences, year to date revenues are 37% ahead of the prior year comparable period. Good organic revenue growth has been boosted by currency benefits on translation and by the acquisitions of BGS and CMI in July and December 2010, respectively. In Seals, year to date revenues are 36% ahead of the prior year comparable period. Strong organic growth, in both the Aftermarket and Industrial OEM businesses, has been augmented by the acquisition of All Seals in September 2010. In Controls, year to date revenues are 14% ahead of the prior year comparable period with good organic growth, unaffected by currency or acquisitions.

 

Financial Position

The Group's cash flow generation has continued to be strong and, as anticipated at the Half Year, growth in working capital has now slowed and overall working capital should begin to fall in the final quarter of the year.

 

As at 29 July 2011, the Group had moved back into a positive net cash position (31 March 2011: £0.9m net debt) and remains well funded. There have been no other material changes in the financial position of the Group in the period since the publication of the Half Year Report for the six months ended 31 March 2011.

 

Outlook

The Directors remain confident in the outlook for the remainder of the year, given the continuing strong overall trading performance.

 

Looking further ahead, whilst recognising the global economic uncertainties and more demanding comparatives, the Group is confident of delivering "GDP-plus" levels of underlying revenue growth. To accelerate overall growth and build further value, we continue to pursue carefully selected, value-enhancing acquisitions, funded by the Group's strong balance sheet and free cash flow.

 

 

Notes:

 

1. This Interim Management Statement, which is based upon unaudited management accounts, has been prepared solely to provide additional information to the shareholders of Diploma PLC in order to meet the requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied on by any other party for other purposes. Certain statements made in this Statement are forward-looking statements. Such statements have been made by the Directors in good faith using information available up until the date that they approved this Statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

2. The Group's results for the year ending 30 September 2011 are expected to be released in mid November 2011.

 

3. A copy of this Statement, together with further information about Diploma PLC, may be viewed on its website at www.diplomaplc.com

 

 

Conference Calls:

 

A telephone conference call will be held with analysts and investors at 8.00am today. Please contact Tulchan Communications for details.

 

 

Enquiries:

 

Diploma PLC -

+44 (0)20 7549 5700

Bruce Thompson, Chief Executive Officer

Nigel Lingwood, Group Finance Director

Tulchan Communications -

+44 (0)20 7353 4200

David Allchurch

Martin Robinson

 

 

NOTE TO EDITORS:

 

Diploma PLC is an international group of businesses supplying specialised technical products and services to the Life Sciences, Seals and Controls industries.

 

Diploma achieves stable growth and attractive margins from its focus on supplying specialised technical products to markets which value high levels of customer service, technical support and value adding activities. A high proportion of revenues are generated from essential products and services funded by operating, rather than capital budgets.

 

The Group employs ca. 850 employees and its principal operating businesses are located in the UK, Germany, US and Canada.

 

Over the last five years, the Group has grown adjusted earnings per share at an average of ca. 14% p.a. through a combination of organic growth and acquisitions. The current market capitalisation is ca. £420m.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEASXNAFKFEFF
Date   Source Headline
1st Jun 20264:00 pmRNSAppointment of Non-Executive Director
21st May 20265:01 pmRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSHalf Year Results
20th Apr 20265:33 pmRNSHolding(s) in Company
9th Apr 20261:16 pmRNSHolding(s) in Company
23rd Mar 20263:02 pmRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSSignificant upgrade to FY26 guidance
27th Feb 20261:45 pmRNSAppointment of Non-Executive Director
27th Jan 20264:06 pmRNSHolding(s) in Company
16th Jan 20263:05 pmRNSDirector/PDMR Shareholding
15th Jan 202610:30 amRNSDirector/PDMR Shareholding
14th Jan 20263:53 pmRNSResult of AGM
14th Jan 20267:00 amRNSQ1 2026 Trading Update
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20251:33 pmRNSHolding(s) in Company
19th Dec 20251:33 pmRNSHolding(s) in Company
18th Dec 202510:52 amRNSHolding(s) in Company
17th Dec 20257:00 amRNSChief Financial Officer appointment
8th Dec 20257:00 amRNSAnnual Financial Report & Notice of AGM
1st Dec 20257:00 amRNSTotal Voting Rights
26th Nov 20257:00 amRNSDirector/PDMR Grant of LTIP Awards
19th Nov 20252:17 pmRNSDirector/PDMR Shareholding
19th Nov 20257:00 amRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSPreliminary Results
13th Nov 20257:00 amRNSIssue of Shares & Total Voting Rights
7th Oct 20257:00 amRNSDirector Declaration
2nd Oct 20252:41 pmRNSHolding(s) in Company
14th Aug 20257:00 amRNSChief Financial Officer update
17th Jul 20257:00 amRNSQ3 Trading Update
2nd Jul 20259:49 amRNSHolding(s) in Company
20th Jun 20259:50 amRNSHolding(s) in Company
9th Jun 202512:50 pmRNSHolding(s) in Company
28th May 20259:27 amRNSHolding(s) in Company
21st May 20254:07 pmRNSDirector/PDMR Shareholding
20th May 20257:00 amRNSHalf-year Report
19th May 202511:02 amRNSHolding(s) in Company
19th May 202510:57 amRNSHolding(s) in Company
9th May 20254:24 pmRNSHolding(s) in Company
6th May 20259:32 amRNSHolding(s) in Company
11th Apr 20253:44 pmRNSHolding(s) in Company
3rd Apr 20257:03 amRNSDirector Declaration
25th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20259:36 amRNSHolding(s) in Company
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
18th Mar 20259:54 amRNSHolding(s) in Company
3rd Mar 202510:15 amRNSDirector Declaration - External Appointment
25th Feb 20257:00 amRNSHolding(s) in Company
14th Feb 20253:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.